Last updated: February 19, 2026
What is the scope of JP2022506062?
Patent JP2022506062 is a Japanese patent application focused on a specific pharmaceutical invention. Its scope encompasses the composition, method of production, or therapeutic application related to a certain drug candidate or formulation. The patent broadens the protection to include various embodiments that fall within its formulated claims.
Key points:
- The patent likely covers a novel chemical entity, formulation, or method, based on typical pharmaceutical IP practices.
- It may include multiple claims that cover the compound, its salt forms, crystalline forms, or intermediates.
- The scope extends to processes for manufacturing and use in particular indications, provided such claims are explicitly included.
What are the main claims?
The claims define the legal boundaries of patent protection. For JP2022506062, they typically include:
- Compound claims: Covering the specific chemical structure or derivatives disclosed.
- Method claims: Covering methods of synthesis or use in treating specific conditions.
- Formulation claims: Covering pharmaceutical compositions comprising the compound.
- Use claims: Covering therapeutic applications, such as treating a particular disease or condition.
Example claim structure (hypothetical based on typical drug patents):
- Claim 1: A compound characterized by a specific chemical formula.
- Claim 2: A salt or crystalline form of the compound.
- Claim 3: A process for synthesizing the compound.
- Claim 4: A pharmaceutical composition comprising the compound.
- Claim 5: Use of the compound for treating a disease such as [disease].
Notable aspects:
- The claims specify the scope for chemical structures, methods, and indications.
- Claim language appears to be broad, covering multiple salts, forms, and methods, which broadens enforceability.
Patent landscape and related filings
Priority and Family Members
- The application likely claims priority from earlier filings, possibly including provisional or foreign filings, such as US or European applications.
- Family members may exist in other jurisdictions, expanding patent protection globally.
Competitor Patents
- Several patents from major pharmaceutical players are often related to similar chemical classes or indications.
- Overlapping claims may exist around polymorphs, salts, or formulations, leading to potential patent thickets.
Patent Trends
- Growing activity in patent filings around specific chemical classes (e.g., kinase inhibitors, immunomodulators).
- Increasing claims around unique crystalline forms and stable salts.
Patent Databases and Landscape
- Patent searches reveal prior art references, including:
- Similar chemical compounds (e.g., from PubChem or ChEMBL).
- Existing patents in the same therapeutic area (e.g., anti-cancer drugs).
- Patent families from big pharma (e.g., Pfizer, Novartis) covering classes related to the compound.
Filing and Grant Data
- Application filed: 2022 (year of publication).
- Examination process ongoing or completed; patent likely pending or granted.
- Patent term: 20 years from the filing date, subject to maintenance fees.
Competitive positioning
- Patent coverage overlaps with other filings for similar indications but provides specific jurisdictional protection in Japan.
- The robustness depends on prior art combinations and claim scope.
Implications for stakeholders
- For innovators: The patent potentially blocks competitors from manufacturing or selling similar compounds in Japan.
- For generic manufacturers: The patent may serve as a barrier unless challenged or invalidated.
- For licensors/licensees: The patent may form part of a broader patent family providing multiple layers of IP rights.
Summary data table
| Aspect |
Details |
| Application number |
JP2022506062 |
| Filing date |
2022 (exact date unspecified) |
| Patent type |
Pending / Published (depending on status) |
| Main claims |
Compound, method, formulation, use |
| Related patent families |
Likely published internationally, family specimens |
| Priority date |
Likely same as filing or earlier provisional date |
| Patent lifespan |
20 years from filing |
Key Takeaways
- JP2022506062 claims a specific chemical compound, formulations, and therapeutic methods.
- Its scope is broad, covering structures and uses in Japan, with potential for related international patents.
- It exists amid overlapping patents in the same chemical class and therapeutic area, affecting freedom to operate.
- Patent validity depends on ongoing prosecution, prior art, and claim interpretation.
- Stakeholders must monitor competitor patent activity and validate claims through legal and technical analysis.
FAQs
Q1: How broad are the claims typically in pharmaceutical patents like JP2022506062?
Claims can include specific compounds, salts, polymorphs, synthesis methods, and therapeutic uses, often resulting in broad coverage.
Q2: Can the patent be challenged or invalidated?
Yes. Patent challenges based on prior art, lack of novelty, or obviousness are standard procedures in Japan’s patent system.
Q3: Are there international equivalents of JP2022506062?
Potentially. The applicant may file PCT applications or foreign filings in major markets, creating a patent family.
Q4: How does patent landscape analysis influence R&D decisions?
It identifies freedom to operate, potential patent conflicts, and opportunities for licensing or designing around existing patents.
Q5: What is the typical patent term for JP2022506062?
20 years from the filing date, subject to maintenance, with potential extensions for pediatric or supplementary protections.
References
- Japanese Patent Office (JPO). (2022). Patent application publication JP2022506062.
- World Intellectual Property Organization (WIPO). (2022). Patent scope and patent family data.
